Clinical Oncology

Article	Citations
RCR Meetings	64
First-line Cemiplimab versus Standard Chemotherapy in Advanced Non-small Cell Lung Cancer Patients with at Least 50% Programmed Cell Death Receptor Ligand-1 Positivity: Analysis of Cost-effectiveness	61
RCR Meetings	54
Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial	39
Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials	36
RCR Meetings	35
An Editorial Review of Prognostic Awareness and Considerations for the Clinical Setting	34
Atomic Theory and Radioactivity	34
Instant Oncology: Lung ART	33
New Guidance From The Royal College of Radiologists on Incidental Irradiation of the Spleen: What Does it Say and Why Does it Matter?	30
Ayrshire Men Diagnosed with Locally Advanced Prostate Cancer between 2012 and 2013; How do they do?	27
Socioeconomic Deprivation Correlates With Incomplete Radiotherapy Treatment in Head and Neck Cancer	25
Reirradiation in Paediatric Tumours of the Central Nervous System: Outcome and Side Effects After Implementing National Guidelines	24
OSAIRIS: Lessons Learned From the Hospital-Based Implementation and Evaluation of an Open-Source Deep-Learning Model for Radiotherapy Image Segmentation	24
Concurrent Chemoradiotherapy versus Radiotherapy Alone in the Treatment of Stage II and T3N0M0 Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis	22
Real World Outcomes in Patients With Recurrent, Advanced, or Metastatic Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab	22
Artificial Intelligence for Radiation Treatment Planning: Bridging Gaps From Retrospective Promise to Clinical Reality	21
Instant Oncology: OPERA	21
Switching to a Fixed-dose Combined Pertuzumab and Trastuzumab With Recombinant Human Hyaluronidase Subcutaneous Injection to Treat Human Epidermal Growth Factor Receptor 2-positive Breast Cancer in Re	20
COVID-19 Vaccine Prioritisation for Medical Students: The Forgotten Cohort?	20
OncoFlash: Research Updates in a Flash!	20
Being a Good Educational Supervisor for Trainee Clinical Oncologists	20
Patient-Reported Outcomes and Health-Related Quality of Life Following Radiotherapy for Bladder Cancer	19
PulMiCC was Not ‘Unsuccessful’ and Stereotactic Ablative Body Radiotherapy is Not Like a Parachute: Comments on the Editorial by Ostler et al.	18
OncoFlash – Research Updates in a Flash! (September Edition)	17

Stereotactic Ablative Radiotherapy for Oligometastatic Disease: A Tale of Emperor's New Clothes or New Standard of Care?	17
RCR Meetings	17
How Low Can You Go? The Radiobiology of Hypofractionation	17
Failing to Close the Gap between Evidence and Clinical Practice in Radical Bladder Cancer Radiotherapy: A Critical Unmet Need	17
RCR Meetings	16
Checklist for Improving Patient Communication on Bladder Preservation Options: The Patient Advocate Perspective	16
The Dawn of Another New Era	16
Survival Outcomes for p16-positive Oropharyngeal Squamous Cell Carcinoma Based on Human Papillomavirus Status	16
RCR Meetings	15
Hypofractionated Radiation Therapy in Keratinocyte Carcinoma	15
RCR Meetings	15
Geometric and Dosimetric Evaluation of a Commercially Available Auto-segmentation Tool for Gross Tumour Volume Delineation in Locally Advanced Non-small Cell Lung Cancer: a Feasibility Study	15
Re: Growth and Nutritional Outcomes in Children Post-haematopoietic Stem Cell Transplant Without Exposure to Total Body Irradiation	15
OncoFlash – Research Updates in a Flash! (April 2023)	15
The Rise of Supportive Oncology: A Revolution in Cancer Care	15
Localised Synovial Sarcoma in Adolescents and Young Adults Versus Adults – Is There a Difference in Outcome?	15
Audit of cabozantinib outcomes for metastatic renal cell carcinoma at Norfolk and Norwich University Hospital	14
Function Preservation in Head and Neck Cancers	14
Instant Oncology: RAPIDO	14
Single institution outcomes of conventional (1.8–2 Gy/Fr) and hypofractionated (2.5–3 Gy/Fr) RT in OG/GOJ cancers during COVID-19	14
SARS-CoV-2 Infection and Antibody Seroprevalence among UK Healthcare Professionals Working with Cancer Patients during the First Wave of the COVID-19 Pandemic	14
Regional Control and Chemoradiotherapy Dose Response for Clinically Involved Lymph Nodes in Patients with Locally Advanced Endometrial Cancers Who are Not Candidates for Upfront Surgical Staging Extra	14
Deep Brain Stimulators and Radiation Therapy in Cancer Patients	14
An educational initiative to develop radiotherapy-specific teaching following the introduction of the oncology common stem year	14
A Single UK Centre's Real-world Experience with Cabazitaxel for Metastatic Castrate Resistant Prostate Cancer	14
Improving Concordance with Radiotherapy Protocols for Patients Undergoing Radical Radiotherapy for Prostate Cancer	14
Hypofractionated radiotherapy for pancreatic cancer	13
Improving Waiting Times from Decision to Treat to Starting Treatment in Head and Neck Cancers: An Audit of the 17-day Pathway	13
Organ preservation in rectal cancer with short-course radiotherapy and a papillon boost: An international multicentre analysis	13
The First Use of Stereotactic Ablative Body Radiotherapy (SABR) in Extra-cranial Non-lung Oligometastatic Disease: A Single Centre	13
Contact X-ray brachytherapy (CXB) for early rectal cancer: A review of outcomes from a single UK centre	13
An Audit of Toxicity from Low-dose Rate (LDR) Prostate Brachytherapy – Assessment of a New Service	13
A Therapeutic Challenge: Chemo-refractory Non-metastatic Inflammatory Breast Cancers	12
Evaluation of the impact of teaching on delineation variation during a virtual SABR contouring workshop	12
‘No one Left Behind’: The Introduction of a Formal Malignancy of Unknown Origin (MUO) Pathway in a Large Regional Cancer Centre	12
3D conformal versus IMRT for early-stage squamous cell carcinoma of larynx	12
Dose to Organ at Risk and its Characteristic Variation with the Clinically Used Different Prescription Levels for Early-stage Left-sided Breast Cancer	12
A Sussex-wide Immunotherapy Toxicity Service to Optimise Patient Care and Redistribute Workload from Tumour-specific Oncologists	12
Treatment outcomes for stage I lung cancer in south-east Scotland	12
Chemoradiotherapy for Muscle-invasive Bladder Cancer; 5-year Survival Outcomes, the Edinburgh Cancer Centre Experience	12
Improving Palliative Radiotherapy Training: A Multi-professional, Combined Clinical and Training Improvement Project	12
A Retrospective Evaluation of Clinical Outcomes of Patients Undergoing Cystectomy for Bladder Cancer at a Specialist Centre; Real-world Data from University College London Hospital	11
Perspectives of Healthcare Professionals on the Management and Treatment of Advanced Ovarian Cancer in the UK: Results From the KNOW-OC Survey	11
OncoFlash – Research Updates in a Flash! (June 2022)	11
3D Conformal Radiotherapy versus Volumetric Modulated Arc Therapy in the Treatment of the Internal Mammary Chain and Supraclavicular Fossa in Adjuvant Breast Radiotherapy	11
Assessing the Value of CT in the Staging and Management of High-risk Prostate Cancer Patients	11
A Dose of Reality: Embracing the Unseen to Improve Stereotactic Radiotherapy	11
Instant Oncology: Impower133	11
Evaluating Delays in Commencing Adjuvant Treatment for Early Breast Cancer Following Oncotype Dx Testing	11
Current Practice of Apalutamide in Patients with Metastatic Hormone-sensitive Prostate Cancer	11

In Response to the Correspondence to the Editor Regarding ʻExtra-mandibular Osteoradionecrosis After the Treatment of Head and Neck Cancer’	11
Salvage Radiotherapy in Localised Prostate Cancer Patients over a 4-year Follow-up Period: Single Centre Analysis	11
Breast Radiotherapy Consent Process in Kent Oncology Centre – a Patient’s Perspective	11
What is so Special About Digital Health in Cancer?	11
In Response to: ‘Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy?’ by Ostler et al. and ‘Should We be Offering our Patients with Oligometastases Stereot	10
Long-term Survival with 18-Fluorodeoxyglucose Positron Emission Tomography-directed Therapy in Non-small Cell Lung Cancer with Synchronous Solitary Brain Metastasis	10
Looking Forward	10
Assessing the Tolerability of Adjuvant and Neoadjuvant Chemotherapy in the Treatment of Early and Locally Advanced Breast Cancer in the Elderly Population at a UK Tertiary Cancer Centre	10
Dosimetry in the Prediction and Reduction of Acute Skin Toxicity from the Use of Brass Bolus in Postmastectomy Chest Wall Radiotherapy Treatment	10
Post-cricoid and Upper Oesophagus Cancers Treated with Organ Preservation Using Intensity-modulated Image-guided Radiotherapy: a Phase II Prospective Study of Outcomes, Toxicity and Quality of Life	10
Response to Mistry: Radiosensitivity index is not fit to be used for dose adjustments: A pan-cancer analysis	9
Clinical Feasibility of Using Single-isocentre Non-coplanar Volumetric Modulated Arc Therapy Combined with Non-coplanar Cone Beam Computed Tomography in Hypofractionated Stereotactic Radiotherapy for	9
Single-centre Experience Comparing PBI to WBRT and the Effects on Volume of Breast Tissue Treated, Heart and Lung Dosimetry	9
Using Proteome Microarray and Gene Expression Omnibus Database to Screen Tumour-Associated Antigens to Construct the Optimal Diagnostic Model of Oesophageal Squamous Cell Carcinoma	9
Rationale and Design of a Phase II Trial of Combined Serplulimab and Chemotherapy in Patients with Histologically Transformed Small Cell Lung Cancer: a Prospective, Single-arm and Multicentre Study	9
The Increasing Role of Genomics Testing in Thyroid Cancers	9
Relapse Rate in Patients Avoiding Adjuvant Chemotherapy Based on Oncotype DX Score – Real-world Data from the Kent Oncology Centre	9
Audit to Evaluate Recurrence Rates in Patients with DCIS Treated with Adjuvant Radiotherapy and the Role of Endocrine Treatment	9
Scientific Developments in Imaging and Dosimetry for Molecular Radiotherapy	9
Health Inequality in Breast Cancer Patients: a Single Institution Review	9
The Beatson Experience of Hydrogel Vue Rectal Spacers in Patients at High Risk of Rectal Toxicity from Prostate Radiotherapy	9
Cell-free DNA Testing in Lung Cancer Patients Improves National Health Service Real-world Result Turnaround Time and Treatment Initiation for Tumours with Targetable Alterations by 4 Weeks	9
Safeguarding Clinical Research in the National Health Service	9
The Clinical Features and Outcomes of Pseudocirrhosis in Breast Cancer: The Royal Marsden Hospital Experience	9
Dosimetric and Clinical Predictors for Acute and Late Gastrointestinal Toxicity Following Chemoradiotherapy of Locally Advanced Anal Cancer	9
Impact of the COVID-19 Pandemic on Radiotherapy Interruptions and Patient Outcomes	9
Interventions for Managing Late Gastrointestinal Symptoms Following Pelvic Radiotherapy: a Systematic Review and Meta-analysis	9
OncoFlash May 2023 Edition	9
OncoFlash–Research Updates in a Flash! (December 2022)	8
Dose-Painting Proton Radiotherapy Guided by Functional MRI in Non-enhancing High-Grade Gliomas	8
Real-world Outcomes of Bladder Carbogen and Nicotinamide (BCON) in Muscle-invasive Bladder Cancer (MIBC)	8
RCR Meetings	8
Study evaluating clinical and histopathological response of neoadjuvant chemotherapy in patients of locally advanced breast cancer - A Prospective Study	8
The “real” outcome of esophageal cancer in elderly.	8
Regarding ‘Assessment of Upfront Selection Criteria to Prioritise Patients for Breath-Hold Left-Sided Breast Radiotherapy’ by Tanna et al	8
Assessing Symmetry and Accuracy of SpaceOAR Insertion Prior to Radical Radiotherapy to the Prostate: a Single UK Centre Experience	8
Provision of Palliative Combined Pembrolizumab–Chemotherapy in Head and Neck Cancer in England: Time for a Review of the Evidence	8
Comparison of VMAT Plans between Clinac iX and Halcyon for Nasopharyngeal carcinoma patients	8
Another Brick in the Wall … no More! Breaking the Sex Bias	8
Role of Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Salivary Glands: A Systematic Review	7
Curative-Intent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck in Sri Lanka: The Impact of Radiotherapy Technique on Survival	7
Clinical Outcomes of Hypo-fractionated Radiotherapy and Intercalated Brachytherapy in Cervical Carcinoma: A Prospective Clinical Study	7
Radiomics in Oncology and Radiology: Statistical Significance Versus Clinical Significance	7
RCR Meetings	7
Defining the Optimal Treatment Strategy in Patients With Uterine Serous Carcinoma	7
Exploiting Deep Learning to Enhance Tumour-conformed Delineation and Reduced Isotropic Margin in Radiotherapy: Updated ESTRO-EANO Guidelines	7
Relationship of Urethral Dose and Genitourinary Toxicity Among Patients Receiving Vaginal High Dose Rate Interstitial Brachytherapy	7
Simultaneous Modulated Accelerated Radiotherapy (SMART) in Intermediate and High Risk Oropharyngeal Squamous Cell Carcinoma	7
Authors' Response to Correspondence Re Ethnic Differences in Radiotherapy Outcomes in a Majority South Asian Leicester Community	7
Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: A Phase II Trial	7
When Less is More: The Rising Tide of Hypofractionation	7
RCR Meetings	7
Decision Regret among Patients with Early-stage Lung Cancer Undergoing Radiation Therapy or Surgical Resection	7
Comparative Analysis of Stereotactic Radiation Therapy and Conventional Radiation Therapy in Cancer Pain Control: A Systematic Review and Meta-Analysis	7
Hidden Neoplasm Detection in Patients With Venous Thromboembolism: An Unresolved Dilemma	7
Real-World Efficacy of Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitors: Results From the Ongoing, Non-interventional VARGADO Study	7
Immunotherapy and Systemic Therapy in Metastatic/Recurrent Endometrial and Cervical Cancers	7
Model-Based Selection for Proton Therapy in Breast Cancer: Development of the National Indication Protocol for Proton Therapy and First Clinical Experiences	7
Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study	7
Combining the Best of Both Worlds: The Role of Sequential Stereotactic Radiotherapy Boost for Spinal Metastases	7
Novel Therapies in Triple-negative Breast Cancer: Can less be More?	6
Is exercise an important consideration in metastatic breast cancer?	6
A Short Report Examining the Introduction of Routine Use of Patient-Reported Outcome Measures in a Mixed Oncology Population	6
What can the Interventional Endoscopist Offer in the Management of Upper Gastrointestinal Malignancies?	6
Systematic Review of Hypofractionated Radiation Therapy for the Treatment of Oesophageal Squamous Cell Carcinoma and Oesophageal Adenocarcinoma	6
Bladder Preservation With Radiotherapy: The Patient Perspective	6
Overall Survival Prognostic Modelling of Non-small Cell Lung Cancer Patients Using Positron Emission Tomography/Computed Tomography Harmonised Radiomics Features: The Quest for the Optimal Machine Lea	6
Accelerated Adaptation of Ultrahypofractionated Radiation Therapy for Breast Cancer at the Time of the COVID-19 Pandemic	6
A retrospective audit of adherence to the IMPORT-HIGH recommendations on clip placement to facilitate breast boost radiotherapy	6
Real-world data (RWD) from patients with triple-negative breast cancer (TNBC) receiving pembrolizumab with neoadjuvant chemotherapy (NACT+P) versus NACT alone	6
Education to Improve Cancer Care for LGBTQ+ Patients in the UK	6
RE: Pharyngeal Constrictor Muscle Sparing in Head and Neck Radiotherapy	6
Dose-dense Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy for Stage IIB/IIIA Non-small Cell Lung Cancer – A Phase II trial	6
The Association Between Survival and Receipt of Post-mastectomy Radiotherapy According to Age at Diagnosis Among Women With Early Invasive Breast Cancer: A Population-Based Cohort Study	6
Watch and Wait in Rectal Cancer After a Complete Response to Chemoradiotherapy – Is It Safe and Are We Doing Enough?	6
Three Proposals to Optimise the Eastern Cooperative Oncology Group and Karnofsky Scales in the Molecular and COVID-19 Era	6
Breast cancer MDT streamlining: Current oncology UK practice	6
Computed Tomography and 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Imaging Biomarkers of Lung Invasive Non-mucinous Adenocarcinoma: Prediction of Grade 3 Tumour Based on W	6
The Time has Come to Say Goodbye	6
A Potential Blind Spot in Breast Radiotherapy: The Importance of Volume in Breast Boosts	6

Geographical Variation in Underlying Social Deprivation, Cardiovascular and Other Comorbidities in Patients with Potentially Curable Cancers in England: Results from a National Registry Dataset Analys	6
Global Longitudinal Strain for the Early Detection of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis	6
Surgical Treatments of Benign Prostatic Hyperplasia and Prostate Cancer Stereotactic Radiotherapy: Impact on Long-Term Genitourinary Toxicity	6
Machine Learning for Auto-Segmentation in Radiotherapy Planning	5
Implementation of Oncotype Dx to Guide Chemotherapy Sparing for Women with Postmenopausal N1-3, ER-positive, HER-2-negative Breast Cancer	5
Endometrial Cancer: Analysing Patterns of Recurrence and Real-Life Outcome Data Using the 2020 ESGO-ESTRO-ESP Risk Stratification System	5
Radiation Therapy in Non-Melanoma Skin Cancers: An Italian Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology	5
Metabolic Profile of Cerebellum in Posterior Fossa Tumor Survivors: Correlation With Memory Impairment	5
Digital Medicine in Men with Advanced Prostate Cancer – A Feasibility Study of Electronic Patient-reported Outcomes in Patients on Systemic Treatment	5
The Management of Oligometastases in Non-small Cell Lung Cancer – is Stereotactic Ablative Radiotherapy now Standard of Care?	5
Study Protocol of the Bladder Adjuvant RadioTherapy (BART) Trial: A Randomised Phase III Trial of Adjuvant Radiotherapy Following Cystectomy in Bladder Cancer	5
Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER)	5
Impact of Adjuvant Treatment in pN3 Penile Cancer	5
Risk-group Classification by Recursive Partitioning Analysis of Patients Affected by Oligometastatic Renal Cancer Treated with Stereotactic Radiotherapy	5
Current Management Practices for Endometrial Cancer (EC) in the UK: A National Healthcare Professional Survey (KNOW-EC)	5
In the Nexus of Transformation: Innovations, Challenges, and the Future of Digital Oncology	5
Response Letter to Laurelli et al. Letter to the Editor Regarding Enhancing Telemedicine to Improve Global Radiotherapy Access	5
South West Regional Experience of Alpelisib and Fulvestrant in Patients with a PIK3CA Mutation	5
Best-Practice Biomarker Testing of Oesophago-Gastric Cancer in the UK: Expert Consensus Recommendations Developed Using a Modified Delphi	5
Time to Rethink Commercialisation: Spin out or Lose out?	5
OncoFlash—Research Updates in a Flash!	5
Developing UK Guidance on How Long Men Should Abstain from Receiving Anal Sex before, During and after Interventions for Prostate Cancer	5
Patient-reported Quality of Life following Stereotactic Body Radiation Therapy for Primary Kidney Cancer – Results from a Prospective Cohort Study	5
Safe and Ethical Artificial Intelligence in Radiotherapy – Lessons Learned From the Aviation Industry	5
The UK National Oesophagogastric Multidisciplinary Team Meeting: An Initiative From the UK & Ireland Oesophagogastric Group	5
Modern Tools for Modern Brachytherapy	5
The Role of Contact X-Ray Brachytherapy in Early Rectal Cancer – Who, when and How?	5
Vascular Interventions in Oncology	5
Can Real-world Data and Rapid Learning Drive Improvements in Lung Cancer Survival? The RAPID-RT Study	5
Audit of Hypersensitivity Reactions (HSRs) of Patients with Breast Cancer being Treated with Nab-paclitaxel after Severe HSR to Prior Taxane Chemotherapy; is it Safe?	5
Analysis of the Safety and Pregnancy Outcomes of Fertility-sparing Surgery in Ovarian Malignant Sex Cord-stromal Tumours: A Multicentre Retrospective Study	5
NICE Technology Appraisals in Breast Oncology and the Impact on Cancer Treatment Unit Activity at the Sussex Cancer Network – 10-year Update	5
Cultivating Inclusivity and Bridging Gaps Through Reverse Mentoring: A Feasibility Study Within the Royal College of Radiologists	5
Imaging of Neck Nodes in Head and Neck Cancers – a Comprehensive Update	5
Pharyngeal Constrictor Dose–Volume Histogram Metrics and Patient-Reported Dysphagia in Head and Neck Radiotherapy	5
Creating a Sustainable Future of Radiotherapy Following COP26: A Case for Lung Stereotactic Ablative Radiotherapy Over Surgery?	5
Significance of Complete Metabolic Response to First-line Taxane/Trastuzumab and Pertuzumab for Advanced HER2+ Breast Cancer: a Single Centre Experience	5
Dual-Centre Harmonised Multimodal Positron Emission Tomography/Computed Tomography Image Radiomic Features and Machine Learning Algorithms for Non-small Cell Lung Cancer Histopathological Subtype Phen	5
A Single-Institution Review of the Use of Radiation in the Adjuvant and Definitive Management of Keloids	5
Variability in Kidney Cancer Treatment and Survival in England: Results of a National Cohort Study	5
Adaptive Radiotherapy in the Management of Cervical Cancer: Review of Strategies and Clinical Implementation	5
The Evidence for Low-level Laser Therapy for Oral Mucositis in Head and Neck Cancer Radiotherapy	5
Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?	5
Response to Mistry: Radiosensitivity Index is Not Fit to be Used for Dose Adjustments: A Pan-Cancer Analysis	4
RCR Meetings	4
National Institute for Health and Care Excellence and Royal College of Radiologists' Fractionation Guideline for Metastatic Spinal Cord Compression	4
OncoFlash – Research Updates in a Flash!	4
The Use of Artificial Intelligence Technologies in Cancer Care	4
Impact of Delay in Healthcare Access on Anal Cancer Diagnosis	4
Sequencing Targeted Therapy in Era of Precision Medicine for Thyroid Cancers	4
RCR Meetings	4
RCR Meetings	4
Recommendations for Multicentre Clinical Trials Involving Dosimetry for Molecular Radiotherapy	4
North-South Divide: Chemo-Immunotherapy Combination in Head and Neck Squamous Cell Cancer (HNSCC)	4
Adopting Machine Learning Auto-Segmentation Into Radiotherapy Workflow	4
The Radiotherapy Learning Healthcare System – Working Together to Improve the Quality of Radiotherapy Nationally	4
Launch of the National Rectal Cancer Intensity-Modulated Radiotherapy Guidance	4
Instant Oncology: FLAME	4
HDR Prostate Brachytherapy Boost for T3b Cancer: The Stokes Centre for Urology Experience	4
Management of Leptomeningeal Carcinomatosis with Intrathecal Chemotherapy (IT) in Breast Cancer Patients: Single Centre Experience from Guy’s Cancer	4
Quality of Radiotherapy Workforce Training within the USA	4
In Reply to Onal et al	4
Early Diagnosis and Lung Cancer Screening	4
Spinal Reirradiation-Mediated Myelopathy: A Systematic Review and Meta-Analysis	4
OncoFlash–Research Updates in a Flash! (Feb 2024)	4
Reflections on the Physics of Compton Scatter	4
Patient-reported Late Effects of Single Fraction Total Body Irradiation for Non-malignant Haematological Disease Transplant Conditioning	4
A Risk-scoring Model for Predicting Post-recurrence Survival in Patients With Endometrial Carcinoma	4
Prospects for Personalised Treatment of Patients with Radioiodine-avid Locally Recurrent or Metastatic Thyroid Cancer	4
Re: Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease	4
OncoFlash – Research Updates in a Flash! (October edition)	4
Clinical Impact of Constitutional Genomic Testing on Current Breast Cancer Care	4
OncoFlash – Research Updates in a Flash! (July 2023)	4
Association of Baseline Patient-reported Health-related Quality of Life Metrics with Outcome in Localised Prostate Cancer	4
Predicting the Risk of Disease Recurrence and Death Following Curative-intent Radiotherapy for Non-small Cell Lung Cancer: The Development and Validation of Two Scoring Systems From a Large Multicentr	4
The Role of Systemic Therapy in Patients with Advanced Non-small Cell Lung Cancer and a Poor Eastern Cooperative Oncology Group Performance Status	4
The National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group Workshop: Translating Novel Discoveries to and from the Clinic	3
Multicentre Trials on Standardised Quantitative Imaging and Dosimetry for Radionuclide Therapies	3
Developing a Paired Whole Genome Sequencing Service for Children With Cancer	3
Causal Inference in Oncology: Why, What, How and When	3
Bladder Cancer: New Insights Into Dose, Volume and Prognostic Biomarkers	3
Overcoming the Chasm Between Evidence and Routine Practice for Bladder Cancer; Just a Quixotic Notion?	3
Review of Conventional and High Dose Rate Brain Radiation (FLASH): Neurobehavioural, Neurocognitive and Assessment Issues in Rodent Models	3
A Randomised Clinical Feasibility Trial of a Breast Immobilisation Device: The SuPPORT 4 All Bra	3
DNA Repair Genetics and the Risk of Radiation Pneumonitis in Patients With Lung Cancer: A Systematic Review and Meta-analysis	3
The Impact of Age on Assessment and Treatment of Breast Cancer in Older People: You Are Only as Old as Your Oncologist Thinks You Are …	3
Instant Oncology: ENACT	3
Growing Evidence for a Need for a Greater Emphasis on Oncology Teaching in Medical School Curricula	3
Brachytherapy for Organ and Function Preservation in Soft-Tissue Sarcomas in Adult and Paediatric Patients	3
Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer: an Updated Systematic Review	3
STAR-TREC: An International Three-arm Multicentre, Partially Randomised Controlled Trial Incorporating an External Pilot	3
Expanding Global Radiotherapy Access via Telemedicine	3
Use of Radiomics Models in Preoperative Grading of Cerebral Gliomas and Comparison with Three-dimensional Arterial Spin Labelling	3
OncoFlash – Research Updates in a Flash! (October 2022)	3
Chimeric Antigen Receptor-Natural Killer Cells: A New Breakthrough in the Treatment of Solid Tumours	3